Antares Pharma Q2 revenue up – Pharmaceutical Business Review

August 9, 2011 by  
Filed under Osteo-Arthritis News

Antares Pharma Q2 revenue up
Pharmaceutical Business Review
the development work for Anturol in anticipation of potential FDA approval of this unique product as well as advancing our next potential product, Vibex MTX, through clinical development for the treatment of Rheumatoid Arthritis," Wotton said.
Antares Pharma gets positive study results with Vibex MTX in rheumatoid pharmabiz.com
Antares Pharma Reports Second Quarter 2011 Financial and Operating ResultsMarketWatch (press release)

all 12 news articles »

More Info: Click here

“Finally, you can have the same Revolutionary Yoga Program top athletes use for TOTAL mind-body fitness ... in just 30 minutes a day!”

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

This blog is kept spam free by WP-SpamFree.

Access denied for user ''@'localhost' (using password: NO)